Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v27-EN Version v13-EN
Language English English
Date Updated 2022-01-14 2021-06-16
Drug Identification Number 02378426 02378426
Brand name LOVENOX LOVENOX
Common or Proper name Lovenox Lovenox
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients ENOXAPARIN SODIUM ENOXAPARIN SODIUM
Strength(s) 60MG 60MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size 10 10
ATC code B01AB B01AB
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2021-12-20 2021-10-01
Actual start date
Estimated end date 2022-01-31 2021-10-08
Actual end date 2022-01-13
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Transportation delay and overselling is leading to a limited supply of product. Allocation will be kept in place to mitigate the anticipated shortage. Transportation delay - The transportation delay is due to the strike at the Montreal Port. In addition, overselling is leading to a limited supply of product. Allocation will be kept in place to mitigate the anticipated shortage.
Health Canada comments